Evaluating Association Between Early Endpoints and Overall Survival and Event-Free Survival in Resectable Non-Small Cell Lung Cancer (Nsclc) Patients Treated with Neoadjuvant Therapy in Cancer Centers in The United States and Europe (France, Germany, And Spain): A Retrospective Patient Chart Study


Total Award Amount

  • 35414.00
  • Direct Costs

  • 26040.00
  • Sponsor Award Id

  • Contributor

  • Benjamin Wei   Principal Investigator